does glp 1 affect bone density GIP, GLP-1, GLP-2, and Mechanisms of GLP-1 effects on

However, as far as we know, most of the literature on dermoscopy related to LMM has primarily been focused on integrated analysis of the mucocutaneous lesions including lips, oral cavity, and vulva (not confined to only lips)3, 5, 6

Most gastrointestinal symptoms, like nausea, typically subside within about eight days

For most medications, this is not needed, but some treatments, such as certain radioactive medicines or chemotherapy drugs, may require a temporary break from breastfeeding

Havent tried the snow cone flavor yet but I think its going to be good

GLP-1RA intervention was associated with a reduction in fasting insulin levels when compared to those given metformin or placebo (MD = 1.40

Severe Allergic Reactions (Anaphylaxis/Severe Hypersensitivity): Symptoms : Swelling of face, lips, tongue, or throat Difficulty breathing or swallowing Severe rash or hives covering large body areas Rapid heartbeat Severe dizziness or lightheadedness Loss of consciousness Action Required : Call 911 immediately - this is life-threatening emergency Use epinephrine auto-injector if available (EpiPen) Do not attempt to drive yourself Inform emergency responders about GLP-1 medication Incidence : Very rare (less than 0.1% of users) Future Use : If severe allergic reaction occurs, cannot use that medication or potentially any GLP-1 medication again Hypoglycemia (Low Blood Sugar): Symptoms : Shakiness or trembling Sweating (cold sweat) Rapid heartbeat or palpitations Dizziness or lightheadedness Hunger Irritability or mood changes Confusion or difficulty concentrating Blurred vision Weakness or fatigue Headache Action Required : Check blood glucose if glucometer available Consume 15-20 grams fast-acting carbohydrates immediately: 4 glucose tablets 4 ounces fruit juice 5-6 pieces hard candy 1 tablespoon honey or sugar Recheck glucose in 15 minutes If still low, repeat treatment Contact healthcare provider same day If severe (unconscious, seizure), call 911 Risk Factors : PRIMARY RISK : Taking GLP-1 medication WITH other diabetes medications that cause hypoglycemia: Insulin (any type) Sulfonylureas (glipizide, glyburide, glimepiride) Meglitinides (repaglinide, nateglinide) GLP-1 medications alone rarely cause hypoglycemia because they're glucose-dependent (only work when glucose elevated) Prevention : Healthcare provider should reduce insulin or sulfonylurea doses when starting GLP-1 medication Monitor blood glucose closely during first weeks Coordinate with diabetes care team Acute Kidney Injury : Symptoms : Decreased urination or no urination Swelling in legs, ankles, feet, face Fatigue or weakness Shortness of breath Confusion or difficulty thinking clearly Nausea Irregular heartbeat Action Required : Contact healthcare provider immediately May require urgent evaluation with lab work May require hospitalization Risk Factors : Severe dehydration (from vomiting or diarrhea) Pre-existing kidney disease Certain medications (NSAIDs, ACE inhibitors, diuretics) Older age Prevention : Maintain adequate hydration, especially during dose increases Monitor for severe GI symptoms Inform provider of any existing kidney disease Diabetic Retinopathy Worsening : Symptoms : Blurred vision or vision changes Floaters (spots in vision) Flashes of light Dark areas or blind spots in vision Difficulty seeing at night Action Required : Contact both healthcare provider AND eye doctor (ophthalmologist) Requires dilated eye examination May require treatment to prevent vision loss Risk Factors : Pre-existing diabetic retinopathy Rapid improvement in blood glucose control Poor glucose control prior to treatment Mechanism : Rapid blood glucose improvements can temporarily worsen retinopathy (paradoxical effect) Prevention : Gradual dose escalation